Riitta Lassila is Professor of Coagulation Medicine at Helsinki University and the head of Coagulation Disorders Unit both in Laboratory Services, HUSLAB and the Hematology and Cancer Center in Helsinki University Central Hospital, Helsinki, Finland. She holds specialty training in Internal Medicine.
Prof Lassila is CSO of Aplagon OY, a company developing antithrombotic molecules. She has served as the associate editor of Thrombosis Research and is a member of the editorial board of Haemophilia. Prof Lassila has authored or co-authored more than 200 peer-reviewed publications, review articles and book chapters.